Freestone Capital Holdings
CLBT icon

Freestone Capital Holdings’s Cellebrite CLBT Stock Holding History

Freestone Capital Holdings’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.67M Buy
+237,499
New +$3.16M 0.07% 169

Other funds holding CLBT

True Wind Capital Management
True Wind Capital Management San Francisco, California $156M AUM 31.3% 1-Year Est. Return
Pertento Partners
Pertento Partners London, United Kingdom $2.09B AUM 28.64% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.8B AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $20.7B AUM 58.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Freestone Capital Holdings's CLBT Position: Q3 2026 in Review

Freestone Capital Holdings opened a new position in Cellebrite (CLBT) in Q3 2026: 237,499 shares worth $2.67M. The stake represents 0.07% of the portfolio and ranks #169 among its holdings.

133 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Freestone Capital Holdings held 237,499 shares of Cellebrite worth $2.67M as of Q3 2026.
  • Cellebrite was a new Freestone Capital Holdings position in Q3 2026.
  • Cellebrite made up 0.07% of Freestone Capital Holdings's portfolio in Q3 2026, its #169 holding.
  • 133 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Freestone Capital Holdings's 13F filing for Q3 2026, filed 9 Nov 2026.